Inactive Instrument
CUSPIS CAP L Stock Toronto S.E.
Stocks
CUSP.P
CA23168X1078
Specialty Chemicals
OTC Markets Traded| Market Cap | 255M 180M 156M 146M 134M 253M 17.14B 1.71B 671M 8.57B 677M 662M 28.4B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 255M 180M 156M 146M 134M 253M 17.14B 1.71B 671M 8.57B 677M 662M 28.4B | EV / Sales 2026 * |
91.2x | EV / Sales 2027 * | 3.5x |
| Free-Float |
86.07% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +14.14% |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Nicol
CEO | Chief Executive Officer | 51 | 2016-08-09 |
Joshua George
DFI | Director of Finance/CFO | - | 2024-04-07 |
Stuart Watson
PRN | Corporate Officer/Principal | - | 2026-04-21 |
| Director | Title | Age | Since |
|---|---|---|---|
Craig Nicol
BRD | Director/Board Member | 51 | 2016-08-09 |
Robert Galyen
BRD | Director/Board Member | - | 2023-06-30 |
Jack Perkowski
CHM | Chairman | 76 | 2023-10-23 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +14.14% | +41.25% | - | - | 179M | ||
| +4.68% | +9.57% | +90.73% | +19.71% | 5.32B | ||
| -3.41% | +21.46% | -17.49% | -33.51% | 3.02B | ||
| +4.51% | +1.52% | -12.45% | +81.29% | 753M | ||
| -2.48% | +1.43% | -5.35% | -46.69% | 641M | ||
| -1.14% | +11.06% | +26.49% | +9.43% | 619M | ||
| +0.77% | +7.61% | -21.75% | -8.50% | 291M | ||
| +0.54% | +23.66% | -31.86% | -35.20% | 277M | ||
| +1.27% | +6.67% | -46.67% | -47.54% | 204M | ||
| Average | +2.10% | +6.78% | -2.29% | -7.63% | 1.39B | |
| Weighted average by Cap. | +1.67% | +9.07% | +36.74% | +1.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.8M 1.98M 1.71M 1.59M 1.47M 2.77M 188M 18.74M 7.36M 93.98M 7.42M 7.26M 311M | 73M 51.5M 44.6M 41.58M 38.24M 72.19M 4.9B 489M 192M 2.45B 193M 189M 8.11B |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Sector
Specialty Chemicals
















